Live Breaking News & Updates on Drug Maker Glaxo Smith Klein

Probably evens itself out. even if democrats do pick up the 10th congressional seat. well, in a move that could have major implications throughout the medical industry, drug maker glax o smith klein will stop paying doctors to promote its drugs. the announcement by the largest drug maker means doctors won t be paid to speak about their drugs at medical conferences and won t be paid to write prescriptions of their drugs or influence prescriptions. gsk is changing the way sales reps are being paid, tieing pay to the quality of services and technical knowledge. this could force other companies to change policies as well given that many have come under fire for their marketing tactic. joining me live now, dr. michael anderson, chief medical officer for university case medical center. good afternoon. i m sure you know better than ....

Drug Maker , Drug Maker Glaxo Smith Klein , The Way , Won T , Sales Reps , Michael Anderson , Marketing Tactic , Case Medical Center , Under Fire ,